Corteva, Inc.

Corteva, Inc.

8.29
EUR
+0.08
(+0.93%)
45.75BMarket Cap
Feb 03Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
18.74
19
19.06
18.47
18.99
21.27
24.22
24.3
24.37
25.59
- -
Basic EPS, GAAP
0.67
3.38
-6.76
-1.28
0.91
2.39
1.59
1.04
1.31
1.61
- -
Free Cash Flow per Basic Share
- -
- -
0.64
1.43
2.76
3.71
1.21
2.5
3.09
5.01
- -
Dividend per Share
- -
- -
3.74
0.68
0.52
0.54
0.58
0.62
0.66
0.7
-0.21
Book Value per Share
- -
- -
99.55
32.47
33.39
34.94
35.47
35.7
34.7
35.92
36.7
Tangible Book Value per Share
- -
- -
69.88
3.55
5.12
7.2
8.41
6.85
6.57
8
9.34
Basic Weighted Avg Shares
749
749
749
750
749
736
721
709
694
680
671
Sales/Revenue/Turnover
14,041
14,240
14,287
13,846
14,217
15,655
17,455
17,226
16,908
17,401
- -
Operating Margin (%)
6.31
1.32
-3.14
4.22
5.93
8.41
11.05
12.25
12.4
15.05
- -
Depreciation Expense
247
270
2,790
1,599
1,177
1,243
1,223
1,211
1,227
1,203
- -
Net Income, GAAP
503
2,534
-5,065
-959
681
1,759
1,147
735
907
1,094
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
22.34
14.73
13.91
32.31
28.67
- -
Profit Margin (%)
3.58
17.79
-35.45
-6.93
4.79
11.24
6.57
4.27
5.36
6.29
- -
Working Capital
- -
- -
9,662
5,281
6,220
5,988
6,051
5,851
4,711
5,210
6,436
LT Debt
- -
- -
5,784
115
1,102
1,100
1,283
2,291
1,953
1,686
3,458
Total Equity
- -
- -
75,153
24,555
25,063
25,623
25,541
25,279
24,030
24,386
24,737
Return on Invested Capital (%)
- -
- -
- -
- -
- -
3.08
5.05
5.67
4.53
6.59
- -
Return on Capital (%)
- -
- -
- -
- -
- -
6.7
4.49
3.38
3.86
4.51
- -
Return on Common Equity (%)
- -
- -
- -
-1.94
2.77
7.01
4.53
2.92
3.72
4.56
- -

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,674
- -
3,988
LT Borrowings
1,682
- -
3,458
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
670
667
667
Market Capitalization
56,107
56,468
51,854

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
17,385
- -
17,886
Cash, Cash Equivalents & STI
1,966
- -
3,933
Accounts Receivable, Net
7,759
- -
6,189
Inventories
5,202
- -
5,482
Total Current Liabilities
11,854
- -
11,450
Payables & Accruals
7,407
- -
7,022
ST Debt
1,674
- -
3,988
Deferred Revenue
2,773
- -
440

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-0.52%
1.48%
Free Cash Flow
- -
29.4%
58.79%
Net Income, GAAP
- -
26.32%
20.62%
Sales/Revenue/Turnover
- -
4.27%
2.92%
Total Cash Common Dividend
- -
4.13%
3.71%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,492
6,112
2,326
3,978
16,908
2025
4,417
6,456
2,618
3,910
17,401
2026
4,905
- -
2,458
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.6
1.51
-0.76
-0.06
1.31
2025
0.95
1.93
-0.47
-0.82
1.61
2026
1.07
- -
-0.85
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.16
0.16
0.17
0.17
0.66
2025
0.17
1.13
-0.79
0.18
0.7
2026
0.18
- -
-0.57
- -
- -

Company Description

CEO
Luke C. Kissam
Full Time Employees
21,500
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
9330 Zionsville Road Indianapolis IN United States 46268
IPO Date
May 24, 2019
Business
Corteva, Inc. Corteva, Inc. (CTVA) develops and supplies advanced seed and crop protection products to enhance agricultural productivity worldwide. The company operates through two primary segments, Seed and Crop Protection; the Seed segment offers high-performance hybrid and traited seeds for row crops such as corn and soybeans under brands including Pioneer and Brevant, alongside specialty seeds for fruits, vegetables, and other crops, supported by digital selection tools and biotechnology traits for insect resistance and herbicide tolerance; the Crop Protection segment provides herbicides including the Enlist system, insecticides, fungicides, nitrogen stabilizers, seed treatments, biologicals, and pasture management solutions to combat weeds, diseases, insects, and nematodes. Corteva serves farmers and the agricultural input industry across more than 140 countries, with a focus on integrated solutions that combine genetics, chemistry, and digital agriculture technologies; it maintains a global manufacturing footprint, robust research and development investment exceeding $1.3 billion annually in genomics, biotechnology, and new active ingredients, and key brands like Pioneer, founded in 1926. Headquartered in Indianapolis, Indiana since 2022 after relocating from Delaware, the company employs over 20,000 people and traces its origins to the 2019 spin-off from DowDuPont as a pure-play agriscience entity. Recent developments include the announcement in late September 2025 of plans to separate into two independent public companies along seed and crop protection lines, with current CEO Chuck Magro to lead the crop protection spin-co; additionally, Corteva entered a strategic collaboration and joint venture with gene-editing firm Pairwise in 2024, investing $25 million in equity to advance climate-resilient crops, and reaffirmed its Delaware presence in October 2025 by relocating corporate offices to downtown Wilmington while retaining over 200 jobs.

Company News

  • 432,151 Corteva, Inc. $CTVA Shares Bought by Aberdeen Group plc

  • Lost Money on Corteva, Inc. Shares? The Law Offices of Frank R.

  • Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

  • Corteva Q3 Earnings Call Highlights

  • Lost Money on Corteva, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 24.30% Share Price Drop

  • Corteva's Q3 Earnings Miss Estimates on Brazil Weakness, Sales Lag

  • Corteva, Inc. (CTVA) Q3 2026 Earnings Call Transcript

  • Why Corteva Stock Dropped on Thursday

  • Corteva Posts Downbeat Q3 Results, Joins Nvidia, Alvotech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

  • Corteva Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

  • Corteva's First Report Since the Vylor Split and Franco-Nevada's Gold-Defying Run Both Face a Test

  • Gear Up for Corteva, Inc. (CTVA) Q3 Earnings: Wall Street Estimates for Key Metrics

  • Corteva's Q3 Earnings on the Horizon: Key Insights for Investors

  • Corteva, Inc. (CTVA) Reports Next Week: Wall Street Expects Earnings Growth

  • Corteva Declares Quarterly Dividend

  • Corteva: A 'Buy' On Constructive Growth And Margin Outlook

  • AgTech & Food Innovation Stocks Driving Smarter Food Systems

  • Corteva Completes Vylor Spin-Off: CTVA Vs. VYLR — Which Stock Is The Better Play Now?

  • Is Corteva Inc (CTVA) Overvalued After 12.3% Rally? GF Value Says Overvalued